Ocular Herpes: Causes, Symptoms, and Treatment

Ocular herpes affects an estimated 500,000 Americans, according to the American Academy of Ophthalmology, making it one of the leading infectious causes of corneal blindness in high-income countries. That's not a rare footnote in medical literature — it's a condition that sits quietly in roughly two-thirds of the world's adult population in its dormant form, waiting for an opportunity. The eye, it turns out, is one of its preferred destinations when it decides to reactivate.

What Causes Ocular Herpes?

The primary culprit is herpes simplex virus type 1 (HSV-1), the same virus responsible for oral cold sores. A smaller subset of cases involves HSV-2, typically associated with genital herpes. After an initial infection — often contracted in childhood through casual contact — the virus travels along sensory nerve pathways and takes up permanent residence in the trigeminal ganglion, a nerve cluster near the base of the skull.

There it stays, latent and largely harmless, until a trigger prompts reactivation. Identified triggers include physical or emotional stress, fever, UV light exposure, hormonal shifts, and immunosuppression. When the virus reactivates and travels back down the ophthalmic branch of the trigeminal nerve, it reaches the eye — specifically the cornea — where it can cause significant damage.

Varicella-zoster virus (VZV), the pathogen behind chickenpox and shingles, causes a distinct but related condition called herpes zoster ophthalmicus (HZO), which accounts for roughly 10–25% of all herpes zoster cases (National Eye Institute).

Recognizing the Symptoms

Ocular herpes doesn't always announce itself dramatically. The first episode is often mild enough to be dismissed as a routine eye irritation. Knowing what to look for matters.

Herpes Simplex Eye Disease typically presents as:

Herpes Zoster Ophthalmicus adds a dermatomal rash along the forehead and tip of the nose (Hutchinson's sign), which strongly predicts ocular involvement. About 50% of HZO patients who show Hutchinson's sign will develop eye complications, per data reviewed by the American Academy of Ophthalmology.

Stromal keratitis — inflammation deeper within the corneal layers — is a more serious manifestation. Unlike surface epithelial disease, stromal keratitis is thought to be partly immune-mediated rather than a direct result of viral replication. It carries real risk of corneal scarring, vision loss, and the kind of structural damage that can only be addressed surgically.

How Ocular Herpes Is Diagnosed

Diagnosis is primarily clinical. A slit-lamp examination is the cornerstone — the characteristic dendritic ulcer is visible with fluorescein dye under cobalt blue light. No laboratory confirmation is required in typical presentations, though viral culture, PCR testing of corneal scrapings, or immunofluorescence assays can confirm HSV or VZV in ambiguous cases.

The CDC notes that HSV-1 seroprevalence in U.S. adults aged 14–49 was approximately 47.8% in the most recent NHANES data cycle, underscoring how broad the reservoir population really is.

Treatment Approaches

The goal of treatment is threefold: suppress active viral replication, reduce inflammation, and prevent recurrence.

Antiviral Therapy

For epithelial (surface) disease, topical antivirals are first-line. Trifluridine 1% eye drops, ganciclovir 0.15% ophthalmic gel, and oral acyclovir are all established options. The NEI-funded HEDS (Herpetic Eye Disease Study) — a landmark multicenter clinical trial — demonstrated that oral acyclovir 400 mg taken twice daily reduced the probability of HSV stromal keratitis recurrence by 41% over a 12-month period in patients with a history of the condition. That finding reshaped prophylactic prescribing practices.

For herpes zoster ophthalmicus, oral antivirals (acyclovir, valacyclovir, or famciclovir) are most effective when initiated within 72 hours of rash onset. Valacyclovir 1,000 mg three times daily for 7 days is a commonly used regimen, with bioavailability advantages over acyclovir.

Corticosteroids

Topical steroids are used carefully — and only in conjunction with antiviral coverage — for stromal keratitis and uveitis. Using steroids without antivirals in active epithelial disease can dramatically worsen outcomes by enabling viral spread.

Surgical Options

Corneal transplantation (penetrating keratoplasty or DALK — deep anterior lamellar keratoplasty) becomes necessary when scarring causes irreversible vision loss. Graft outcomes in HSV keratitis patients are generally favorable but require continued antiviral prophylaxis post-operatively to reduce recurrence risk.

Managing Recurrence

Ocular herpes recurs. The HEDS data found that patients with a history of one recurrence faced a 32% probability of another episode within 2 years without suppressive therapy. Long-term oral acyclovir at 400 mg twice daily remains the most studied suppressive regimen, with a well-established safety profile over extended use.

Patients with frequent recurrences, immunosuppressive conditions (including post-transplant regimens or HIV), or prior corneal scarring are candidates for indefinite prophylaxis — a clinical decision made in partnership between the patient and their ophthalmologist.

References

The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)